Curative endoscopic therapy in patients with early esophageal squamous-cell carcinoma or high-grade intraepithelial neoplasia

Background and study aims: Endoscopic resection of esophageal squamous-cell neoplasia with curative intent is considered to be a safe and effective alternative treatment to radical surgery in cases where the neoplasia is intraepithelial or limited to the mucosal layer. These patients are at risk for recurrent malignancy in the preserved esophagus, however. We conducted a prospective study to evaluate the efficacy and safety of endoscopic resection and to analyze variables associated with recurrence in patients with mucosal or intraepithelial squamous-cell neoplasia.

Patients and methods: Between December 1997 and September 2005, 65 patients (mean age ± standard deviation [SD] 62.9 ± 9.5 years), 12 with high-grade intraepithelial neoplasia (HGIN) and 53 with mucosal squamous-cell cancer, were included in our study and were treated using endoscopic resection. Details of patient and tumor characteristics were documented prospectively. All patients were included in a staging protocol including high-resolution endoscopy with Lugol staining, endoscopic ultrasound, computed tomography, and abdominal ultrasound. Endoscopic resection was performed using a ligation technique. The data acquired were subjected to univariate and multivariate analysis.

Results: A total of 179 resections were performed (mean number of resections ± SD per patient, 2.8 ± 1.8): 11/12 patients with HGIN (91.7 %), and 51/53 patients with mucosal cancer (96.2 %) achieved a complete response during a mean follow-up period of 39.3 ± 22.8 months; three patients were still under therapy at the end of the study period. Recurrence of malignancy after achieving a complete response was observed in 16 patients (26 %), but these patients all achieved another complete response after further endoscopic treatment. Independent risk factors for recurrence was multifocal carcinoma (RR 4.1, P = 0.018). Tumor-related deaths occurred in two patients (3 %), and eight patients died as a result of co-morbidity. Complications were seen in 15/65 patients (23 %, all esophageal stenoses). The 7 year survival rate calculated for all groups was 77 %.

Conclusions: According to the results of long-term follow-up in this study, endosocopic resection appears to be an effective and safe method of curative treatment in patients with HGIN and mucosal squamous-cell carcinomas of the esophagus. Multifocal carcinoma and T1m1 tumors seem to be highly associated with recurrence.

References

• 1 Messmann H. Squamous cell cancer of the oesophagus.  Best Pract Res Clin Gastroenterol. 2001;  15 249-265
• 2 Takeshita K, Tani M, Inoue H. et al . Endoscopic treatment of early esophageal or gastric cancer.  Gut. 1997;  40 123-127
• 3 Makuuchi H. Endoscopic mucosal resection for early esophageal cancer: indication and techniques.  Dig Endosc. 1996;  8 175-179
• 4 Pech O, Gossner L, May A. et al . Endoscopic resection of superficial esophageal squamous-cell carcinomas: Western experience.  Am J Gastroenterol. 2004;  99 1226-1232
• 5 Soehendra N, Binmoeller K F, Bohnacker S. et al . Endoscopic snare mucosectomy in the esophagus without any additional equipment: a simple technique for resection of flat early cancer.  Endoscopy. 1997;  29 380-383
• 6 Giovannini M, Bernardini D, Moutardier V. et al . Endoscopic mucosal resection (EMR): results and prognostic factors in 21 patients.  Endoscopy. 1999;  31 698-701
• 7 Gossner L, May A, Sroka R. et al . Photodynamic destruction of high-grade dysplasia and early cancer of the esophagus after the oral administration of 5-aminolevulinic acid.  Cancer. 1999;  86 1921-1928
• 8 Katada C, Muto M, Manabe T. et al . Local recurrence of squamous-cell carcinoma of the esophagus after EMR.  Gastrointest Endosc. 2005;  61 219-225
• 9 Nishi M, Omori Y, Miwa K. Japanese classification of gastric carcinoma. Japanese Research Society for Gastric Cancer. 1st English edn. Tokyo; Kanehara 1995
• 10 Ell C, May A, Gossner L. et al . Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett’s esophagus.  Gastroenterology. 2000;  118 670-677
• 11 Pech O, May A, Gossner L. et al . Barrett’s esophagus: endoscopic resection.  Gastrointest Endosc Clin N Am. 2003;  13 505-512
• 12 May A, Gossner L, Pech O. et al . Intraepithelial high-grade neoplasia and early adenocarcinoma in short-segment Barrett’s esophagus (SSBE): curative treatment using local endoscopic treatment techniques.  Endoscopy. 2002;  34 604-610
• 13 Behrens A, May A, Gossner L. et al . Curative treatment for high-grade intraepithelial neoplasia in Barrett’s esophagus.  Endoscopy. 2005;  37 999-1005
• 14 Grambsch P, Therneau T. Proportional hazards tests and diagnostics based on weighted residuals.  Biometrika. 1994;  81 515-526
• 15 Stein H J, Feith M, Bruecher B L. et al . Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection.  Ann Surg. 2005;  242 566-573
• 16 Tanabe S, Koizumi W, Kokutou M. et al . Usefulness of endoscopic aspiration mucosectomy as compared with strip biopsy for the treatment of gastric mucosal cancer.  Gastrointest Endosc. 1999;  50 819-822
• 17 Araki K, Ohno S, Egashira A. et al . Pathologic features of superficial esophageal squamous cell carcinoma with lymph node and distal metastasis.  Cancer. 2002;  94 570-575
• 18 Pech O, Gossner L, May A. et al . Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett’s cancer and high-grade intraepithelial neoplasia.  Gastrointest Endosc. 2005;  62 24-30
• 19 Gossner L, Stolte M, Sroka R. et al . Photodynamic ablation of high-grade dysplasia and early cancer in Barrett’s esophagus by means of 5-aminolevulinic acid.  Gastroenterology. 1998;  114 448-455
• 20 Radu A, Wagnieres G, van Den Bergh H. et al . Photodynamic therapy of early squamous cell cancers of the esophagus.  Gastrointest Endosc Clin N Am. 2000;  10 439-460
• 21 Overholt B F, Panjehpour M, Halberg D L. Photodynamic therapy for Barrett’s esophagus with dysplasia and/or early stage carcinoma: long-term results.  Gastrointest Endosc. 2003;  58 183-188
• 22 Hölscher A H, Bollschweiler E, Schneider P M. et al . Early adenocarcinoma in Barrett’s oesophagus.  Br J Surg. 1997;  84 1470-1473
• 23 Thomas P, Doddoli C, Neville P. et al . Esophageal cancer resection in the elderly.  Eur J Cardiothorac Surg. 1996;  11 941-946
• 24 Hoelscher A H, Bollschweiler E, Schneider P M. et al . Prognosis of early esophageal cancer: comparison between adeno- and squamous cell carcinoma.  Cancer. 1995;  76 178-186
• 25 Tajima Y, Nakanishi Y, Ochiai A. et al . Histopathologic findings predicting lymph node metastasis and prognosis of patients with superficial esophageal carcinoma: analysis of 240 surgically resected tumors.  Cancer. 2000;  88 1285-1293
• 26 Kato H, Tachimori Y, Mizobuchi S. et al . Cervical, mediastinal, and abdominal lymph node dissection (three-field dissection) for superficial carcinoma of the thoracic esophagus.  Cancer. 1993;  72 2879-2882
• 27 Matsubara T, Ueda M, Abe T. et al . Unique distribution patterns of metastatic lymph nodes in patients with superficial carcinoma of the thoracic oesophagus.  Br J Surg. 1999;  86 669-673
• 28 Igaki H, Kato H, Tachimori Y, Nakanishi Y. Cervical lymph node metastasis in patients with submucosal carcinoma of the thoracic esophagus.  J Surg Oncol. 2000;  75 37-41
• 29 Fujita H, Sueyoshi S, Yamana H. et al . Optimum treatment strategy for superficial esophageal cancer: endoscopic mucosal resection versus radical esophagectomy.  World J Surg. 2001;  25 424-431
• 30 Kodama M, Kakegawa T. Treatment of superficial cancer of the esophagus: a summary of responses to a questionnaire on superficial cancer of the esophagus in Japan.  Surgery. 1998;  123 432-439
• 31 Shimizu Y, Kato M, Yamamoto J. et al . EMR combined with chemoradiotherapy: a novel treatment for superficial esophageal squamous-cell carcinoma.  Gastrointest Endosc. 2004;  59 199-204